This study not only uncovered the ATF-3/miR-590/GOLPH3 signaling pathway on regulating the breast cancer proliferation, but provides a new diagnosis marker and therapeutic target based on miRNA regulation for future breast cancer clinical treatment. This evidence concerns the gene ATF3 and breast cancer.